Sign in to baba News

One account across the web, iPhone and Android — your subscription follows it.

or use an email code

Welcome — one more step

News Plus opens the cross-newsroom layer — who covered a story, who didn’t, and how each one worded it.

  • Ask Duki without the monthly limit — answers from the coverage, with sources
  • Save articles, synced between the web and the app
  • How each newsroom worded the same event
  • Filing timeline and coverage breakdown
  • The whole archive, searchable
  • Unlimited newsroom, topic and people follows
  • The daily brief by email, in English or Hebrew

Eligible new subscribers get 7 days free, then $34.99 each year. Renews automatically until cancelled. Cancel any time in your account. Subscription terms.

Your subscription also unlocks the app.

Search stories

Type at least two characters. Results come from every newsroom baba reads.

to move · to open · esc to close

Live Terminal

Sign in to baba News

Sign in to keep asking. News Plus removes the daily limit.

or use an email code

Keep the whole picture

News Plus opens the cross-newsroom layer — who covered a story, who didn’t, and how each one worded it.

  • Ask Duki without the monthly limit — answers from the coverage, with sources
  • Save articles, synced between the web and the app
  • How each newsroom worded the same event
  • Filing timeline and coverage breakdown
  • The whole archive, searchable
  • Unlimited newsroom, topic and people follows
  • The daily brief by email, in English or Hebrew

Eligible new subscribers get 7 days free, then $34.99 each year. Renews automatically until cancelled. Cancel any time in your account. Subscription terms.

Your subscription also unlocks the app.

New Daily Pill for Obesity Expected to Launch in Israel Post-Holiday

By אביחי חיים - כתב בריאות ורווחהUpdated Sep 11, 2026
Translated & summarized from Hamal by baba
The story · English

A new daily pill designed to combat obesity is anticipated to become available in Israel following the upcoming holiday period. The medication, which has shown promising results in clinical trials, offers a new therapeutic option for individuals struggling with weight management.

Details regarding the specific brand name, manufacturer, and exact launch date are expected to be released closer to the availability period. Health officials and medical professionals are reportedly preparing for the introduction of this new treatment, which could potentially impact public health strategies concerning obesity in the country. Further information on prescription requirements and accessibility is also anticipated.

Read the original at Hamal
Full coverage · 10 outlets
89% centerFirst: Ynet · Sep 10

The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.

Center 8Right 1Unrated 1
Related stories · 5

Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.

Open the live terminal